John B. Harlow Jr. - 04 Dec 2025 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
Chief Commercial Officer
Signature
/s/ Sheldon L. Koenig, by power of attorney
Issuer symbol
ESPR
Transactions as of
04 Dec 2025
Transactions value $
$0
Form type
4
Filing time
08 Dec 2025, 16:27:31 UTC
Previous filing
17 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Harlow John B. Jr. Chief Commercial Officer C/O ESPERION THERAPEUTICS, INC., 3891 RANCHERO DRIVE, SUITE 150, ANN ARBOR /s/ Sheldon L. Koenig, by power of attorney 08 Dec 2025 0002095554

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ESPR Common Stock Award $0 +425K $0.00 425K 04 Dec 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ESPR Stock Option (right to buy) Award $0 +380K $0.00 380K 04 Dec 2025 Common Stock 380K $3.79 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Such award will vest over a four (4) year period as follows: 25% shall vest on the respective one year anniversary of the vesting commencement date of December 15, 2025 and the remainder shall vest in equal quarterly installments over the three (3) year period thereafter.